Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ELTP has broken SMA200. This could start a run up ahead. Next attempt is .22, then .30. GL!
Trump's drug price war policy will be a game changer for generic drug maker like ELTP. ELTP also billion-dollar market drugs in the pipeline. This stock is one of my speculative long stocks which is expected to have at least 10x return. Strong Buy!
http://solidstockmove.wordpress.com
Just come to say Hello to all bulls and bears here. Based on my research, this stock, ELTP, is a strong buy now. This will be over 50 in 2017.
Merry Christmas and Happy new year!
That's how a penny stock does: dilution, dilution, then reverse split, reverse split, then dilution again, never end. The same such typical action is applied to ELTP. Everything else is only promised, but never gets done. Get back to 10-15 cents soon. Watch out!
They diluted 38,407,721 shares more; looks really bad to me. $9M net loss, $1.3M negative cash flow. What else Elite does besides share dilution and cash burning? Looks like this company is gonna file for bankruptcy soon.
$9.6M net loss, $1.3M negative cash flow. What are they doing with investor's cash? I guess they will continue burn cash to dead; more shares will be diluted soon; and reverse split comes.
The news is so negative for longs, too bad! Getting back to 7 cents next week.
net loss of $9.6M, revenue only $1.2M, incurred $1.3m negative cash flow. This company burns cash like crazy. Sell off will be big tomorrow. Will see 7-8 cents next week.
EPIC sold Elite shares, no confidence here. It is tanking back to 8 cents.
Loan money means Elite doesn't have partnership support. Seems like no Pharma is interested in Elite ART. $1M is only enough to pay salary for executives in 1 or 2 months, no more left even for employees. I guess they will make another loan or share dilution next month.
Loan money, dilute shares, then loan more money, then dilute more shares, ... Elite keeps repeating this song year by year, never end. I'm wondering when they will stop this? Did all money go to the air?
Before you say it has 20% cut of the oxy market; one question: has ART passed any trials yet?
Failed trials = nothing!
I guess he sold all shares with 30% profit. No proof of buy or sell. Everyone can post either way. I don 't believe a CEO just say "Hey boy , I just bought 11M shares, now your turn". Oh well, if he said that, then this company turns out to be a P&D.
Bad deal for Elite, I would say. The license fee is only paid in the percentage of gross profit. Haha, EPIC will report that they have revenue from drugs selling but no profit left due to a lot of expenses, salaries for sellers, etc. No profit = no payment to Elite. Oh well, good deal for EPIC, bad deal for Elite.
If the payment is based on revenue, that can be called a good deal. So bad!
Just stop by and see this drops from .15 to .12 in a few days. Oh well, not surprised. When do they vote for a 20:1 reverse split?
3 things:
1) Now, its number of shares is more than 10 times when it was on AMEX. No serious investors will jump in a company with 500M shares in OTC.
2) You say as if its ART already passed all trial phases. For a microcap company like this, 99% it will fail trials.
3) While Elite does its trials, do other companies sleep and let Elite take their market?
Well, the Street guys don't think so; that's why the ELTP is now (<15 cents), no more.
Well, do you know how much is Pfizer or Actavis revenue? Revenue of ELTP is just a joke, not enough to pay their operations, salaries and bonds. They still didn't pay bonds for many years.
The stock is in OTC and penny for a reason, my friend. The street is smart enough to evaluate its value. Just follow it!
Why no need? I see they not only do RS, but also will dilute more shares. They need money for trials, and pay bonds. The number of shares increases from 40M to near 500M in just a few years. ELTP looks like a share-printing machine to me.
After the pump, dump comes, we even see under .10. If patient, can get 0.8 soon.
All market green today; while ELTP downs like Titanic. That's how OTC works, heaven of naked shorts, longs become bag holders. Reverse split is only way to get of OTC. ELTP should do it soon, 20:1 is good.
ELTP falls like rock after the bump. 10 cents is where it feels comfortable with, not now. Reverse split and dilution ahead also scare buyers.
The question is whether they have enough cash for doing trials in 2 years as you said. They even didn't pay for the bond yet. They will dilute hundreds of million shares more for survival. RS is unavoidable before dilution to have more money in less dilution amount. You will see share price get back to 10 cents range before we here any news on ART progress, for sure.
I would like to quote Feuerstein-Ratain rule: "no company with less than $300M market cap will has a positive phase 3 trial". Well, with current Elite stage, it would be fail, 100% fail, no doubt!
Let do more research on this rule, you will understand.
trials may be take them at least 3 years. 90% fail rate. If they can handle to succeed the phase 3 trial, at least 1 more year to have first product shipment. I'm doubt they have enough cash to survive in next 4 years without dilution. To make dilution more cash-efficient, RS will be made first. Well, long way for longs, but good for day traders, like me, I suppose!
It takes years for trials, and trials have normally more than 90% fail rate, you know that. So, it has a very long way to get ART to market or you may never see that. RS is a must to get more institutions involved before we see any progress on ART.
At that time the number of shares is 20M, now 500M shares. A reverse split of 20:1 or 25:1 will get this company back to 2006 stage. I believe RS will happen this year or early next year. Without RS, ELTP will get stuck in OTCBB trash forever.
No magic here, an over-bought stock must pullback, no surprise. It may close below 0.13 today. You guys can reentry at much lower level.
ELTP overbought; RSI reaches 90; will pull back quickly for correction. Take your profits before too late, I suggest.
Well, 10% loss will kill 20% gain, easy!
this stock will go no where with 500M shares. Reverse split of 10:1 will happen in this year or early next year. Watch out for a big sell off coming in next few days.
They sell for 0.25 a share; so the market reflected that well. Will consolidate around that price for a while before any news comes.
hahaha. That guy is a good entertainer, though.
INO AH 1.96
ZLCS 52-week high is 1.52. It will hit this high back this month.
I love to see it grows slow and steady rather up fast then down fast. Hopefully we will hold above 1.5 this week, and ready for pop next week with news.
the daily chart looks very good. All RSI, MACD and volume are in place. The trend shows 2.0 will be revisited in a few days. If partnership news comes next week, 3.5-4.0 will be its stop.
Happy trading, all!
reverse split is a must, no another choice for ELTP.
BTW, a lot of great bio stocks out there; why leave dead money in here?
Will get back in after this stock does a RS. 10:1 or 20:1 RS is good.
A lot of OS shares with little average volume shows no interests from investors. Just naked shorts, day traders and flippers are manipulating the stock here. Reserve split is a must to have this stock healthy. 10:1 is good; 20:1 would also be fine.
I will buy only after RS done.
Too much selling pressure. Well, today is Friday, we can understand.
I keep telling you guys that ELTP will go no where if it is still in OTC. I don't bash; I love to see it grow as you guys; but you guys must be realistic. Still in OTC, still get naked shorts, heavily manipulated and flipped, highly violated, and goes no where. I has played ELTP in more than 3 years; love its potential and also hate it because of OTC trading.
Reserve split is not a bad thing as you guys think. Let reduce number of shares and go to Nasdaq. ELTP has great potential, but no serious investors want to jump in if it is still in OTC.
I expect a RS of 20:1 at the end of this year or early next year. I still keep a small position; but will not add until it does RS and get uplisted to Nasdaq.
GLTA!
Dr. Kim said in last CC: this is a epic year for INO; let buy INO shares! I'm taking take his advice.
5.0 year end target with good news. I smell a huge partnership news ahead. Let see.